RWD360 is a vast repository of pan tumor clinical data for broad analyses with the highest epidemiological relevance. Validated AI models enrich data for scale; claims linkage provides more complete insights into patient journeys.
Compare demographic characteristics based on different treatments.
See Treatment Sequencing
See how treatments and drug class exposures being sequenced in a cohort.
Combine Clinical Criteria
Understand which patients have a combination of clinical criteria, like ECOG and smoking status, and see the distribution of values for the cohort.
Customer Value for RWD360
Clinical Development Leaders
Rapidly generate insights into standard of care with on-demand access to thousands of data elements and accelerate innovation and drug development timelines.
Data Scientist & Trial Analytics Experts
Use advanced analytics and data science integrated with large real-world datasheets to work in new ways and optimize study design and execution.
Chief Development Officers
Centralize enterprise data needs with the ability to easily combine disparate datasets and shorten clinical development workflows with rich data and data science technologies.
Expertly Abstracted Data for Regulatory Purposes and Publication
Patient360 is an off-the-shelf, deeply abstracted data product that removes the need for bespoke curation and allows direct insights into current standard of care on emerging disease and treatment dynamics.
Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival
See results from findings presented at ISPOR 2020 and ASCO 2020 on the performance of proxy measures against directly-observed measures of PFS by using structured and unstructured information from ConcertAI’s Oncology Real-World Database.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.